Related Experiment Video

Updated: Jun 28, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells

Han-A Kim1, Hyun-Mi Ko, Hye-Won Ju

  • 1Department of Biological Sciences, College of Natural Sciences, Chonnam National University, Gwangju 500-757, Republic of Korea.

Cancer Letters
|October 28, 2008
PubMed

Insights

Synthetic oligodeoxynucleotides (CpG-ODN) activate innate immunity and show promise in cancer therapy. This study demonstrates CpG-ODN

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Synthetic oligodeoxynucleotides (ODN) with unmethylated CpG motifs (CpG-ODN) stimulate innate immunity via toll-like receptor 9.
  • CpG-ODN's immunomodulatory properties are linked to anti-tumor immunity, suggesting potential therapeutic applications.

Purpose of the Study:

  • To evaluate the efficacy of CpG-ODN-based immunotherapy in inhibiting established and distant tumor metastasis.
  • To assess CpG-ODN's impact on pulmonary metastasis in murine B16F10 melanoma and CT26 colon cancer models.

Main Methods:

  • Utilized murine B16F10 melanoma and CT26 colon cancer models.
  • Administered CpG-ODN systemically at various time points relative to tumor cell injection and surgical removal of primary tumors.
  • Monitored inhibition of pulmonary colonization and growth of metastasized tumor cells.

Main Results:

  • Systemic CpG-ODN administration significantly inhibited pulmonary colonization in the B16F10 melanoma model.
  • CpG-ODN administration also reduced pulmonary metastasis in the CT26 colon cancer model, even after primary tumor removal.
  • CpG-ODN demonstrated efficacy in inhibiting the growth of already established pulmonary metastases.

Conclusions:

  • CpG-ODN-based immunotherapy effectively inhibits pulmonary metastasis and the growth of metastasized tumor cells in preclinical cancer models.
  • These findings suggest CpG-ODN may be a valuable therapeutic strategy for controlling micrometastasis, particularly in post-surgical clinical settings.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...